Abstract
Time constraints and professional demands leave practicing professionals unlikely to enroll in extended training such as a semester-long graduate course. Thus, the three-hour continuing education format has become a standard for those in practice. One may ask what sorts of training strategies optimize that format. To explore that, a three-hour training program for seventy-six practicing mental health professionals, most of whom self-identified as psychologists, was devised. It made use of primarily antecedent techniques that have been shown to bring about changed perceptions on a number of topics. Content focused on two areas of importance to behavior analysts, the culture’s increasing acceptance of the biological causation model of disorders such as attention-deficit hyperactivity disorder (ADHD), unipolar depression, anxiety disorders, and schizophrenia, and the field’s increasing reliance on medications, often to the exclusion of behavioral methods. Pre-post assessment showed that participants had changed their thinking regarding the two content areas. The authors caution that participants’ changed opinions may serve as setting events to changes in practice, but those changes are verbal. One must not assume changes in practice techniques will automatically occur.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Abramson, L. Y., Metalsky, G. I., & Alloy, L. B. (1989). Hopelessness depression: A theory-based subtype of depression. Psychological Review, 96, 358–372. https://doi.org/10.1037/0033-295X.96.2.358
Allen, M., & Preiss, R. W. (Eds.). (1998). Persuasion: Advances through meta-analyses. Creskill, NJ: Hampton Press.
Andreason, N. C., & Black, D. W. (2001). Introductory Textbook of Psychiatry (3rd Ed). Washington DC: American Psychiatric Publishing.
APA Practitioner Focus (1990). CAPP v. RANK: Out of the courts, into the legislature? 4, 2.
Angell, M. (2000). Is academic medicine for sale? New England Journal of Medicine, 342, 1516–1518. https://doi.org/10.1056/NEJM200005183422009
Antonuccio, D. O., Danton, W.G., DeNelsky, G.Y., Greenberg, R. G., & Gordon, J.S., (1999). Raising questions about antidepressants. Psychotherapy and Psychosomatics. 68, 3–14. https://doi.org/10.1159/000012304
Antonuccio, D.O., Danton, W.G., & DeNelsky, G.Y. (1995). Psychotherapy versus medication for depression: Challenging the conventional wisdom with data. Professional Psychology Research and Practice, 26, 574–585. https://doi.org/10.1037/0735-7028.26.6.574
Aronson, E. & Golden, B. W. (1962). The effect of relevant and irrelevant aspects of communicator credibility on opinion change. Journal of Personality, 30, 135–146. https://doi.org/10.1111/j.1467-6494.1962.tb01680.x
Baesler, E. J. (1997). Persuasive effects of story and statistical evidence. Argumentation and Advocacy. Downloaded July 18, 2010 from https://doi.org/findarticles.com/p/articles/mi_hb6699/is_n4_v33/ai_n28698259/
Berlo, D. K., Lemest, J. B., & Martin, R. J. (1969). Dimensions for evaluating the acceptability of message sources. Public Opinion Quarterly, 33, 563–576. https://doi.org/10.1086/267745
Blanton, H., & Jaccard, J. (2006). Arbitrary metrics in psychology. American Psychologist, 61(1), 27–40. https://doi.org/10.1037/0003-066X.61.1.27
Booth-Butterfield, S. (2005). Assumptions of the dual process approach. Primer of Practical Persuasion and Influence. [On-line]. Available: https://doi.org/dmoz.org/science/social_science/psychology/social/persuasion_and_social_influence/
Brennan, T. A., Rothman, D. J., Blank, L., Blumenthal, D., Chimonas, S. C., Cohen, J.J., et al. (2006). Health industry practices that create conflicts of interest: A policy proposal for academic medical centers. Journal of the American Medical Association, 295, 429–433. https://doi.org/10.1001/jama.295.4.429
Buie, J. (1989). APA brief focuses on psychologists’ training. The APA Monitor, 17–18.
Burrell, N. A., & Koper, R. J. (1998). The efficacy of powerful/powerless language on attitudes and source credibility. In M. Allen & R. W. Preiss (Eds.), Persuasion: advances through meta-analyses (pp. 203–216). Creskill, NJ: Hampton Press.
Caruso, D. B. (2006, November 3). Med students taught to resist drug pitches. The Charleston Gazette, p. 3A.
Cialdini, R. B. (2001). Influence: Science and practice. Boston: Allyn & Bacon.
Dillard, J. P., & Pfau, M. (2002). The persuasion handbook: Developments in theory and practice. Thousand Oaks, CA: Sage.
Eagly, A. H., Wood, W., & Chaiken, S. (1978). Causal inferences about communicators and their effect on opinion change. Journal of Personality and Social Psychology, 36, 434–435. https://doi.org/10.1037/0022-3514.36.4.424
FDA Science Board (November, 2007). FDA science and mission at risk. Retrieved July 2, 2008, from: https://doi.org/www.fda.gov/ohrms/dockets/ac/o7/briefing/2007-4329b_02_01_FDA.
Fox, R. E. (2002, July/August). Medicine, psychiatry use time-worn claims to discredit psychologists. The National Psychologist, pp. 1, 4.
French, J. & Raven, B. H. (1959). The bases of social power. In D. Cartwright (Ed.), Studies in social power. Ann Arbor, MI: Institute for Social Research.
Gottesman, I. I. (1991). Schizophrenia genesis: The origins of madness. New York: Freeman.
Haard, J., Slater, M. D. & Long, M. (2004). Scientese and ambiguous citations in the selling of unproven medical treatments. Health Communication, 61, 411–426. https://doi.org/10.1207/s15327027hc1604_2
Hales, R. E. & Yudofsky, S. C. (2003). Textbook of clinical psychiatry (3rd Ed.). Washington DC: American Psychiatric Publishing.
Harris, G. (October 4, 2008). Top psychiatrist failed to report drug income. Retrieved October 3, 2008 from https://doi.org/www.nytimes.com/2008/10.04/health/policy/04drug.html?
Haugtvedt, C. P. & The Consumer Psychology Seminar (1997). Journal of Consumer Psychology, 6, 99–106. https://doi.org/10.1207/s15327663jcp0601_07
Hepner, K. A., Rowe, M., Rost, K., Hickey, S. C., Sherbourne, C. D., Ford, D. E., Meredith, L. S., & Rubenstein, L. V. (2007). The effect of adherence to practice guidelines on depression outcomes. Annals of Internal Medicine, 147, 320–329. https://doi.org/10.7326/0003-4819-147-5-200709040-00007
Hollon, S. D. (1996). The efficacy and effectiveness of psychotherapy relative to medications. American Psychologist, 51, 198–206. https://doi.org/10.1037/0003-066X.51.10.1025
Hopper, J. A., Speece, M. W., & Musia, J. L. (1997). Effects of an educational intervention on residents’ knowledge and attitudes toward interactions with pharmaceutical representatives.
Journal of General Internal Medicine, 12, 639. https://doi.org/10.1046/j.1525-1497.1997.07126.x Horowitz, A. V., Wakefield, J. C. (2007). The loss of sadness: How psychiatry transformed normal sorrow into depressive disorder. New York: Oxford University Press.
Jacobson, N. S., & Hollon, S. D. (1996). Cognitive-behavioral therapy versus pharmacotherapy: Now that the jury’s returned its verdict, it’s time to present the rest of the evidence. Journal of Consulting and Clinical Psychology, 64(1), 74–80. https://doi.org/10.1037/0022-006X.64.1.74
Johnson, L. A. (September 11, 2008). Medical schools, journals fight industry influence. USAToday Online. Retrieved September 5, 2009 from https://doi.org/www.usatoday.com/news/health/2008-09-11-3564233893_x.htm.
Joseph, J., & Leo, J. (2006). Genetic relatedness and the lifetime risk for being diagnosed with schizophrenia: Gottesman’s 1991 figure 10 reconsidered. The Journal of Mind and Behavior, 27, 73–90.
Kerr, N. L. (2002). When is a minority a minority? Active versus passive minority advocacy and social influence. European Journal of Social Psychology, 32, 471–483. https://doi.org/10.1002/ejsp.103
Khan, A., Leventhal, R., Khan, S., & Brown, W. (2002). Severity of depression and response to antidepressants and placebo: An analysis of the Food and Drug Administration database. Journal of Clinical Psychopharmacology, 22(1), 40–45. https://doi.org/10.1097/00004714-200202000-00007
Kirsch, I., & Sapirstein, G. (1998). Listening to Prozac but hearing placebo: A meta-analysis of antidepressant medication. Prevention & Treatment, 1, Article 0002A. Available on the World Wide Web: https://doi.org/journals.apa.org/prevention/volume1/pre0010002a.html.
Kirsch, I., & Weixel, L. (1988). Double-blind versus deceptive administration of a placebo. Behavioral Neuroscience, 102(2), 319–323. https://doi.org/10.1037/0735-7044.102.2.319 Kopfman, J. E., Smith, S. W., Ah Yun, J. K., & Hodges, A. (1998). Affective and cognitive reactions to narrative versus statistical evidence organ donation messages. Journal of Applied Communication Research, 26, 279–300. https://doi.org/10.1080/00909889809365508
Kravitz, R., Epstein, R., Feldman, M., Franz, C., Rahman, A., Wilkes, M., Ladson, H., & Franks, P. (2005). Influence of patients’ requests for direct-to-consumer advertised antidepressants. A randomized controlled trial. Journal of American Medical Association. 293, 1995–2002.
Lacasse, J. R., & Leo, J. (2005). Serotonin and depression: A disconnect between the advertisements and the scientific literature. PloS Medicine, 2, 1–6.
Leuchter, A., Cook, I., Witte, E., Morgan, M., & Abrams, M. (2002). Changes in brain function of depressed subjects during treatment with placebo. American Journal of Psychiatry, 159, 122–129. https://doi.org/10.1176/appi.ajp.159.1.122
Levasseur, D., & Dean, K. W. (1996). The use of evidence in presidential debates: A study of evidence levels and types from 1960 to 1988. Argumentation and Advocacy, 32(4), 129–142.
Link, B. G., Struening, E. L., Rhav, M., Phelan, J. C., & Nuttbrock, L. (1997). On stigma and its consequences: Evidence from a longitudinal study of men with dual diagnoses of mental illness and substance abuse. Journal of Health and Social Behavior, 38(2), 177–190. https://doi.org/10.2307/2955424
Londborg, P., Wolkow, R., Smith, W., DuBoff, E., England, D., Ferguson, J., et al. (1998). Sertraline in the treatment of panic disorder. British Journal of Psychiatry, 173, 54–60. https://doi.org/10.1192/bjp.173.1.54
Lydiard, B., Steiner, M., Burnham, D., & Gergel, I. (1998). Efficacy studies of paroxetine in panic disorder. Psychopharmacology Bulletin, 34(2), 175–182.
Lundberg, G. D. (2008, April 3). Placebo as good as paroxetine for treating acute moderate-to-severe depression. The Medscape Journal of Medicine, Article 79. Retrieved July 1, 2008, from https://doi.org/www.pubmedcentral.nih.gov/articlerender.fegi?artid=2390688.
McCroskey, J. C. (1969). A summary of experimental research on the effects of evidence in persuasive communication. Quarterly Journal of Speech, 55(2), 169–176. https://doi.org/10.1080/00335636909382942
Millenson, M. L., & Shalowitz, M. (2005). Getting doctors to say yes to drugs: The cost and quality impact of drug company marketing to physicians. Blue Cross Blue Shield Assocation. Retrieved December 20, 2005 from https://doi.org/www.bcbs.com/coststudies/reports/Drug_Co_Marketing_Report.pdf
MindFreedom (2003, July 28, August 12, 22, September 26). Fast for freedom in mental health. Retrieved December 22, 2003, from https://doi.org/www.mindfreedom.org/mindfreedom/hungarstrike1.stml.
Mineka, S., & Zimbarg, R. (2006). A contemporary theory perspective on the etiology of anxiety disorders: It’s not what you thought it was. American Psychologist, 61, 10–26. https://doi.org/10.1037/0003-066X.61.1.10
Nelson, B. (1982, November 2). Psychiatry suffers anxiety as popular career. New York Times Service, p. C1.
Nierenberg, A., McLean, N., Alpert, J., Worthington, J., Rosenbaum, J. F., & Fava, M. (1995). Early non-response to fluoxetine as a predictor of poor 8-week outcome. American Journal of Psychiatry, 152, 1500–1503.
O’Keefe, D. J. (1998). Justification explicitness and persuasive effect: A meta-analytic review of the effects of varying support articulation in persuasive messages. Argumentation and Advocacy, 35, 61–75.
Olfson, M., Blanco, C., Liu, L., Moreno. C., & Laje, G. (2006). National trends in outpatient treatment of children and adolescents with antipsychotic drugs. Archives of General Psychiatry, 63, 679–685. https://doi.org/10.1001/archpsyc.63.6.679
Petty, R. E. & Cacioppo, J. T. (1986). Communication and persuasion: Central and peripheral routes to attitude change. New York: Springer-Verlag.
Pelham, W. (2009). Unpublished research.
Perloff, R. M. (1993). The dynamics of persuasion. Hillsdale, NJ: Lawrence Erlbaum.
Pincus, H. A., Tanielian, T. L., Marcus, S. C., Olfson, M., Zarin, D. A., & Thompson, J. (1998). Prescribing trends in psychotropic medications: Primary care, psychiatry and other medical specialties. Journal of American Medical Assocation, 279, 526–531.
Pohl, R., Wolkow, R., & Clary, C. (1998). Sertraline in the treatment of panic disorder: A doubleblind multicenter trial. American Journal of Psychiatry, 155, 1189–1195.
Reinard, J. C. (1988). The empirical study of the effects of evidence: The status after fifty years of research. Human Communication Research, 15, 3–59. https://doi.org/10.1111/j.1468-2958.1988.tb00170.x
Reynolds, R. A., & Reynolds, J. L. (2002). Evidence. In J. P. Dillard & M. Pfau (Eds.), The persuasion handbook (pp. 427–444). Thousand Oaks, CA: Sage.
Ross, C. M. W. (2008). SSRI ads questioned. Canadian Medical Association Journal NEWS. Retrieved July 1, 2008, from https://doi.org/www.cmaj.ca/cgi/content/full.174/6/754-a.
Ryan, C. S., & Hemmes, N. S. (2005). Effects of the contingency for homework submission on homework submission and quiz performance in a college course. Journal of Applied Behavior Analysis, 38, 79–88. https://doi.org/10.1901/jaba.2005.123-03
Saville, B. K., Zinn, T. E., Neef, N. A., Van Norman, R., & Ferreri, S. J. (2006). A comparison of interteaching and lecture in the college classroom. Journal of Applied Behavior Analysis, 39, 49–61. https://doi.org/10.1901/jaba.2006.42-05
Schul, Y., & Mayo, R. (1999). Two sources are better than one: The effects of ignoring one message on using a different message from the same source. Journal of Experimental Social Psychology, 35, 327–345. https://doi.org/10.1006/jesp.1999.1379
Seamon, H. (1997, January/February). Illinois professional school first to start prescription curriculum. The National Psychologist, pp. 1, 3.
Seligman, M. (1975). Helplessness: On depression, development, and death. San Francisco: W.H. Freeman.
Skinner, B. F. (1956) What is psychotic behavior? In F. Gildea (Ed.), Theory and treatment of the psychoses: Some newer aspects (pp. 77–99). St. Louis: Committee on Publications, Washington University.
Skinner, B. F. (1974). About behaviorism. New York: Alfred A. Knopf.
Slater, M. D., & Rouner, D. (1996). How message evaluation and source attributes may influence credibility assessment and belief change. Journalism & Mass Communication Quarterly, 73(4), 974–991. https://doi.org/10.1177/107769909607300415
Smith, R. (2005). Medical journals are an extension of the marketing arm of pharmaceutical companies. Health Letter: Public Citizen Health Research Group, 21(7), 1–3.
Sommers-Flanagan, J., & Sommers-Flanagan, R. (1996). Efficacy of antidepressant medication with depressed youth: What psychologists should know. Professional Psychology: Research and Practice, 27(2), 145–153. https://doi.org/10.1037/0735-7028.27.2.145
Special Issue on Mental Illness, Mental Health, and Cultural Analytic Science (2006). Behavior and Social Issues, 15(2).
Special Section: Behavior Analysis, Biological Determinism, and Biological Psychiatry (2007). Behavior and Social Issues, 16(2).
Steinman, M. A., (2000). Gifts to physicians in the consumer marketing era. Journal of American Medical Association, 284, 2243. https://doi.org/10.1001/jama.284.17.2243-JMS1101-4-1
Steinman, M. A., Shlipak, M. G., & McPhee, S. J. (2000). Of principles and pens: Attitudes and practices of medical house staff toward pharmaceutical industry promotions. Journal of General Internal Medicine. (15).
Stettin, G. D., Yao, J., Verbrugge, R., & Aubert, R. E. (2006). Frequency of follow-up care for adult and pediatric patients during initiation of antidepressnt therapy. American Journal of Managed Care. Downloaded August 3, 2009, from https://doi.org/www.highbeam.com/doc/1G1-171580067.html.
Terry, C., & Kohlenberg, R. J. (2006, May). The implications of the medical model of mental health on mental health and social policies. Poster session presented at the annual meeting of the Association for Behavior Analysis, Atlanta GA.
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008). Selective publication of antidepressant trials and its influence on apparent efficacy. The New England Journal of Medicine, 358, 252–260. https://doi.org/10.1056/NEJMsa065779
U. S. Department of Health and Human Services (1999). Mental health: A report of the surgeon general – Executive summary. Rockville, MD: U.S. Department of Health and Human Services, Center for Mental Health Services, National Institutes of Health, National Institute of Mental Health.
Valenstein, E. (1998). Blaming the brain. New York: McGraw-Hill.
Wahl, O. F. (1999). Mental health consumers’ experience of stigma. Schizophrenia Bulletin, 25, 467–478. https://doi.org/10.1093/oxfordjournals.schbul.a033394
Winston, M. (2006). A behavioral analytic look at mental disorders, the DSM-IV, and functional effects of psychotropic medications. Paper presented at the meeting of the Association for Behavior Analysis, Atlanta, GA.
Wong, S. E. (2006a, May). Behavioral versus biomedical treatments for schizophrenia and depression. Paper presented at the meeting of the Association for Behavioral Analysis, Atlanta, GA.
Wong, S. E. (2006b). Behavior analysis of psychotic disorders: Scientific dead end or casualty of the mental health political economy? Behavior and Social Issues, 15, 152–177. https://doi.org/10.5210/bsi.v15i2.365
Wong, S. E. (2007). Scientific discovery, social change and individual behavior change. Behavior and Social Issues, 16, 190–196. https://doi.org/10.5210/bsi.v16i2.1951
Wyatt, W. J. (2006, May). Psychiatry’s flight from science: A profession’s headlong, non-empirical rush to biological explanations. Paper presented at the meeting of the Association for Behavior Analysis, Atlanta, GA.
Wyatt, W. J., (2003, May). Biological causation in the professional and popular cultures: Tactics for dealing with an oversold model. Workshop presented at the Association for Behavior Analysis, San Francisco.
Wyatt, W. J. (1993). Identical twins, emergenesis, and environments. American Psychologist, 48, 1294–1295. https://doi.org/10.1037/0003-066X.48.12.1294.b
Wyatt, W. J., & Midkiff, D. M. (2006a). Biological psychiatry: A practice in search of a science. Behavior and Social Issues, 15, 132–151. https://doi.org/10.5210/bsi.v15i2.372
Wyatt, W. J., & Midkiff, D. M. (2006b). Six-to-one gets the job done: Comments on the reviews. Behavior and Social Issues, 15, 222–231. https://doi.org/10.5210/bsi.v15i2.388
Wyatt, W. J., & Midkiff, D. M. (2007). Psychiatry’s thirty-five-year, non-empirical reach for biological explanations. Behavior and Social Issues, 16, 197–213. https://doi.org/10.5210/bsi.v16i2.1874
Wyatt, W. J., Posey, A., Welker, W., & Seamons, C. (1984). Base rates of similarities and differences between identical twins and between unrelated people. The Skeptical Inquirer, 9, 62–66.
Zimmerman, M., Chelminski, I., & Posternak, M.A. (2004) Exclusion criteria used in antidepressant efficacy trials: Consistency across studies and representativeness of samples included. Journal of Nervous and Mental Disease, 192, 87–94. https://doi.org/10.1097/01.nmd.0000110279.23893.82
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Midkiff, D.M., Wyatt, W.J. Has Behavioral Science Tumbled Through The Biological Looking Glass? Will Brief, Evidence-Based Training Return it from the Rabbit Hole?. Behav. Soc. Iss. 19, 94–125 (2010). https://doi.org/10.5210/bsi.v19i0.2240
Published:
Issue Date:
DOI: https://doi.org/10.5210/bsi.v19i0.2240